Gland Pharma Ltd.
GLAND Share PricePharmaceuticals & Drugs
₹1,878.1
-14.1 (-0.7%)
As on September 8, 2025
Exchange Scrips: BSE543245NSEGLANDISININE068V01023
Market Cap ₹ 30,809 Cr
P/E Ratio 44.3
Dividend Yield 0.96 %
Performance
Market performance
Open1,900.5
High1,909.4
Volumes79,151
Prev1,878.1
Low1,856
As on2025-09-08
Historical performance
1 Year High2,131
3 Year High2,460
5 Year High4,350
1 Year Low1,277.8
3 Year Low861
5 Year Low861
Fundamentals
Company Valuation
Market Cap (₹Cr)
30,809
Face Value (₹)
1
P/E Ratio
44.3
Dividend Yield
0.96 %
Investment Returns
1 Year
-1.5%
3 Years
-23.1%
5 Years
N/A
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 1,880.02 | Bearish |
| 10-DMA | 1,889.8 | Bearish |
| 20-DMA | 1,919.58 | Bearish |
| 50-DMA | 1,935.56 | Bearish |
| 100-DMA | 1,745.4 | Bullish |
| 200-DMA | 1,691.88 | Bullish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 5 | 5 | 5 | 5 | 5 |
| Foreign Investors | 5 | 5 | 5 | 5 | 5 |
| Domestic Investors | --- | --- | --- | --- | --- |
| Public Investors | 110666 | 113783 | 121070 | 122353 | 122660 |
| Government | 1 | 1 | 1 | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 44.3.
- 3Y Stock Price CAGR of the stock is -7.7.
- The stock has a beta of 0.8.
- In the last financial year, the company had an EBITDA of ₹14825 Million.
- The company generated revenue of ₹56165 Million in the previous financial year.
Gland Pharma Ltd.
1878.1-14.1 (-0.7%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 989176.5
No. of Shares: 527 (Approx)
Performance:-1.1%
P/L: ₹-10823.5
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent